Le Lézard
Classified in: Health
Subjects: HSP, BFA, DEI

One of the Most Advanced Specialty Pharmacies in the Region Opens in Westchester, Accelerating Access to Life Altering Medications


BRONX, N.Y., Feb. 8, 2024 /PRNewswire/ -- Today, Montefiore Health System unveiled its new Montefiore Specialty Pharmacy in Westchester, one of the largest and most technologically advanced hospital-owned specialty pharmacies in the Tri-State area. The 17,000 square-foot facility provides complex and high-cost medications to people with rare and chronic conditions and is tackling financial barriers?establishing a new standard of care in the region.

Specialty pharmacies provide medications that have specific requirements for medication storage, dosing and management. First emerging in the 1970s, specialty pharmacies have experienced tremendous growth in recent years, with increasing rates of chronic conditions and intricate treatments that may require unique refrigeration and compounding capabilities.

Montefiore Specialty Pharmacy is comprised of a dedicated pharmacy team who advocate for patients, ensuring timely prescription fulfillment and medication management for individuals with a wide range of conditions including cancer, rheumatologic, neurologic and immune disorders, as well as gastrointestinal and other inflammatory diseases.

Key factors that distinguish Montefiore Specialty Pharmacy include:     

This new site is Montefiore's second specialty pharmacy location. Its first specialty pharmacy, located at its Henry and Lucy Moses Division in the Bronx, opened in 2019.

"Our new specialty pharmacy is designed to be an extension of a patient's care team," said Steven Tuckman, M.B.A., director, Community and Specialty Pharmacy Operations, Montefiore. "Before dispensing medications, our clinical pharmacists communicate with our patients to help ensure they understand their treatment regimens and possible side effects. This same team follows up to confirm that medications are taken as prescribed, and by having a 24/7 answering service, we can be a resource at any hour."

Tuckman projects that nearly 100,000 scripts will be filled in the first year, primarily from the Bronx and Westchester, with plans to expand.

Enhancing Experiences for Patients & Providers

Chronic disease exacts a significant toll on the health and well-being of New Yorkers. More than 40 percent of New York adults suffer from at least one chronic disease, making medication management vital. Childhood rates of chronic health problems including asthma and diabetes have also been on the rise.

The Montefiore Specialty Pharmacy team is charged with enabling faster delivery of prescriptions as well as securing insurance authorizations for time-sensitive medications, alleviating time and stress from patients and providers alike.

"The specialty pharmacy has already made a tremendous impact on my ability to deliver the highest quality care to my patients who have cancer," says Ioannis Mantzaris, M.D., leukemia and blood cancer specialist at Montefiore Einstein Comprehensive Cancer Center. "Before the specialty pharmacy opened, my clinical team and I used to spend roughly three hours per drug for each patient to secure insurance authorizations. Now, this team is enabling more of my patients to access important first-line therapies, and they have given me great peace of mind knowing my patients are getting the prescriptions they need."

Focused on improving access to care and treatments, last year Montefiore helped secure $45.7 million in financial assistance for patient prescriptions by identifying programs available from outside organizations. 

"We're always searching for opportunities across the health system to better support the community," said Susan Green-Lorenzen, R.N. M.S.N., system senior vice president of operations at Montefiore. "Just because someone has cancer does not mean their other chronic illnesses like heart disease or inflammatory diseases go away. This new specialty pharmacy brings us one step closer toward making sure people with the most complicated conditions get the very best and most comprehensive care, easier and faster than ever before."

About Montefiore Health System

Montefiore Health System is one of New York's premier academic health systems. It is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester, and the Hudson Valley. It comprises ten hospitals, including the Children's Hospital at MontefioreBurke Rehabilitation Hospital, and over two hundred outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information, please visit www.montefiore.org. Follow us on TwitterInstagram and LinkedIn, or view us on Facebook and YouTube.

SOURCE Montefiore Health System


These press releases may also interest you

at 07:15
The National Business League (NBL)®, National Medical Association (NMA)®, and National Bar Association (NBA)® are proud to announce a collaborative effort to address critical issues impacting Black communities. This initiative focuses on protecting...

at 07:05
Natera, Inc. , a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that its latest research and data on prenatal and reproductive genetics will be presented at the 28th International Conference on Prenatal Diagnosis and...

at 06:58
"According to the latest BCC Research study, the demand for "Global Recombinant Proteins Market" is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through...

at 06:30
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Has Signed a ?37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium ? July 3, 2024, 12:30pm CET / 6:30am ET ? Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)...

at 06:30
Increasing pet ownership and the trend of treating pets as family members, the rising demand for livestock products due to a growing global population, and the need to manage zoonotic diseases to protect public health are some factors driving the...

at 06:00
The report "Anti-Migrating Agent Market by Type (Non-ionic, Anionic, Cationic, Amphoteric), Grades (Technical, Food, Pharmaceutical), Application, Chemistry (Organic, Inorganic), End-Use Industry (Textile, Plastics, Paper), and Region - Global...



News published on and distributed by: